Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer (Q64819117)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer |
clinical trial |
Statements
Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (English)
0 references
23 February 2016
0 references
22 February 2018
0 references
12
0 references
18 year
0 references